Merimepodib – 10 mg

Brand:
Cayman
CAS:
198821-22-6
Storage:
-20
UN-No:
Non-Hazardous - /

Merimepodib is an inhibitor of inosine-5′-monophosphate dehydrogenase (IMPDH; Kis = 7 and 10 nM for IMPDH type I and type II, respectively) with antiviral and immunosuppressant activities.{53250} It reduces Ebola, Lassa, chikungunya, Junin, and Zika virus titers in vitro and inhibits Zika virus replication in Huh7 cells (EC50 = 0.6 µM).{53251} Merimepodib inhibits the proliferation of PHA-stimulated T cells and SPAS-stimulated B cells (IC50s = 104 and 132 nM, respectively), effects that can be reversed by guanosine (Item No. 27702) but not adenosine (Item No. 21232).{53252} In vivo, merimepodib (50 and 100 mg/kg) increases allograft survival in a murine skin transplantation model and prevents development of graft versus host disease (GVHD) in splenocyte allografted mice.{53253}  

 

Available on backorder

SKU: 29351 - 10 mg Category:

Description

An IMPDH inhibitor (Kis = 7 and 10 nM for IMPDH type I and type II, respectively); reduces Ebola, Lassa, chikungunya, Junin, and Zika virus titers in vitro and inhibits Zika virus replication in Huh7 cells (EC50 = 0.6 µM); inhibits the proliferation of PHA-stimulated T cells and SPAS-stimulated B cells (IC50s = 104 and 132 nM, respectively); increases allograft survival in a murine skin transplantation model and prevents development of GVHD in splenocyte allografted mice


Formal name: N-[[3-[[[[3-methoxy-4-(5-oxazolyl)phenyl]amino]carbonyl]amino]phenyl]methyl]-carbamic acid, (3S)-tetrahydro-3-furanyl ester

Synonyms:  VX-497

Molecular weight: 452.5

CAS: 198821-22-6

Purity: ≥98%

Formulation: A crystalline solid